Clinical trial

Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

NCT02560051

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-11-01

PhasePHASE2

Study timeline

Study start (unknown)2015-11-01Date precision: month

Registry last updated2018-11-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Interventions

DoxorubicinDRUG · verified · RxNorm: doxorubicin

KetoconazoleDRUG · verified · RxNorm: ketoconazole

DocetaxelDRUG · verified · RxNorm: docetaxel

EstramustineDRUG · verified · RxNorm: estramustine

DegarelixDRUG · verified · RxNorm: degarelix

Sponsors & collaborators

The University of Texas Health Science Center, Houstonlead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02560051 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.